Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kona Medical completes $30mm Series C financing; adds $10mm

Executive Summary

Kona Medical Inc. (hypertension therapy) has raised $30mm through its Series C venture round. Led by an undisclosed large-cap medical technology company, Kona’s existing shareholders Essex Woodlands, Domain Associates, Morgenthaler Ventures, BioStar Ventures, and five other undisclosed investors also participated in the financing.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies